|
2024
|
Invention
|
Arenavirus formulations, methods and uses thereof. The present disclosure relates to improved liq... |
|
|
Invention
|
Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vacci... |
|
2023
|
Invention
|
Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines.
Pro... |
|
|
Invention
|
Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines. Prov... |
|
2022
|
Invention
|
Cmv vaccines.
Provided herein are genetically modified arenaviral vectors suitable as vaccines f... |
|
|
Invention
|
Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associ... |
|
|
Invention
|
Hpv vaccines.
Provided herein are genetically modified arenaviruses suitable as vaccines against... |
|
|
Invention
|
Tri-segmented pichinde viruses as vaccine vectors.
The present application relates to Pichinde v... |
|
|
Invention
|
Arenaviruses as vectors.
The present application relates to arenavirus particles containing a ge... |
|
|
Invention
|
Arenaviruses as vectors. The present application relates to arenavirus particles containing a gen... |
|
|
Invention
|
Arenaviruses used in treatments of prostate cancer.
The present application relates to arenaviru... |
|
|
Invention
|
Arenaviruses used in treatments of prostate cancer. The present application relates to arenavirus... |
|
|
Invention
|
Arenavirus particles as cancer vaccines.
The present application relates generally to geneticall... |
|
2021
|
Invention
|
Vaccines against hepatitis b virus.
The present application provides immunotherapies for Hepatit... |
|
|
Invention
|
Cancer treatment strategies using arenavirus vectors.
The present application relates generally ... |
|
|
Invention
|
Cancer treatment strategies using arenavirus vectors. The present application relates generally t... |
|
2020
|
Invention
|
Hpv vaccines. Provided herein are genetically modified arenaviruses suitable as vaccines against ... |
|
2019
|
G/S
|
Treatment of materials for the manufacture of preparations for active and passive immunization in... |
|
|
G/S
|
Pharmaceutical and veterinary preparations, in particular preparations for active and passive imm... |
|
2018
|
Invention
|
Cmv vaccines. Provided herein are genetically modified arenaviral vectors suitable as vaccines fo... |
|
|
G/S
|
(Based on 44(e)) Pharmaceutical and veterinary preparations for active and passive immunization, ... |
|
|
Invention
|
Arenavirus particles to treat solid tumors.
The present application relates generally to genetic... |
|
|
Invention
|
Arenavirus particles to treat solid tumors. The present application relates generally to genetica... |
|
|
Invention
|
Arenavirus particles to treat solid tumors. The present application relates generally to ge... |
|
2017
|
Invention
|
Tri-segmented pichinde viruses as vaccine vectors. The present application relates to Pichinde vi... |
|
2016
|
Invention
|
Arenavirus particles as cancer vaccines. The present application relates generally to genetically... |
|
|
Invention
|
Vaccines against hepatitis b virus. The present application provides immunotherapies for Hepatiti... |
|
|
Invention
|
Modified arenavirus vectors for use as vaccines against hepatitis b virus. The present applicatio... |
